Moracizine hydrochloride
データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます
29560-58-5CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2.[Cl-].[H+]GAQAKFHSULJNAK-UHFFFAOYSA-N29560-58-5安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
説明Moricizine hydrochloride is a phenothiazine derivative with antiarrhythmic activity developed by the Soviet Academy of Medical Sciences. It is licensed to Dupont-Sanko in a joint venture. Moricizine hydrochloride is the first drug licensed to a U.S. company by the Soviet Union and was introduced by Dupont in the U.S. in 1990 for specific use in Iife-threatening ventricular arrhythmias. This narrow indication reflects its proarrhythmic potential. The incidence of this adverse reaction, however, is lower than that of other antiarrhythmic agents.
使用Cardiac depressant (anti-arrhythmic).
定義ChEBI: A hydrochloride salt obtained from equimola amounts of moricizine and hydrogen chloride.
現在のフィルター条件では反応記録がありません。
読み込み中…